Royal Bank Of Canada Agios Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 38,142 shares of AGIO stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,142

Previous 41,772 8.69%

Holding current value

$2.12 Million

Previous $1.8 Million 5.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $149,519 - $180,483	-3,630 Reduced 8.69%	38,142 $1.69 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $245,993 - $436,003	-8,929 Reduced 17.61%	41,772 $1.8 Million
Q1 2024 Nov 05, 2024	BUY	$21.32 - $34.81 $190,366 - $310,818	8,929 Added 21.38%	50,701 $1.48 Million
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $124,572 - $203,394	-5,843 Reduced 10.33%	50,701 $1.48 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $50,823 - $62,428	2,545 Added 4.71%	56,544 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $100,606 - $116,383	4,130 Added 8.28%	53,999 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $105,745 - $144,373	4,946 Added 11.01%	49,869 $1.41 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $12,565 - $17,877	-578 Reduced 1.27%	44,923 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $98,247 - $124,819	3,960 Added 9.53%	45,501 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $187,588 - $328,256	9,615 Added 30.12%	41,541 $1.18 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $113,210 - $208,503	6,636 Added 26.24%	31,926 $708,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $87,377 - $114,002	-3,275 Reduced 11.47%	25,290 $735,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $58,183 - $97,917	-1,967 Reduced 6.44%	28,565 $940,000
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $254,286 - $352,919	6,066 Added 24.79%	30,532 $1.41 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $1.27 Million - $1.5 Million	24,466 New	24,466 $1.35 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Agios Pharmaceuticals, Inc. Transaction History